Eukaryotic Prekallikrein (PK)

KLKB1; KLK3; Fletcher Factor; Kallikrein B,Plasma; Kininogenin; Plasma prekallikrein

  • Product No.EPB801Hu62
  • Organism SpeciesHomo sapiens (Human) Same name, Different species.
  • SourceEukaryotic expression
  • Host293F Cell
  • Endotoxin Level<1.0EU per 1µg (determined by the LAL method)
  • Subcellular LocationSecreted
  • Predicted Molecular Mass70.8kDa
  • Accurate Molecular Mass72kDa(Analysis of differences refer to the manual)
  • Residues & TagsGly20~Ala638 with N-terminal His Tag
  • Buffer FormulationPBS, pH7.4, containing 5% Trehalose.
  • Traits Freeze-dried powder
  • Purity> 90%
  • Isoelectric Point8.2
  • Applications Positive Control; Immunogen; SDS-PAGE; WB.
    If bio-activity of the protein is needed, please check active protein.
  • DownloadInstruction Manual
  • UOM 10µg50µg 200µg 1mg 5mg
  • FOB US$ 164  US$ 410  US$ 820  US$ 2460  US$ 6150 
    For more details, please contact local distributors!

SEQUENCE

USAGE

Reconstitute in 10mM PBS (pH7.4) to a concentration of
0.1-1.0 mg/mL. Do not vortex.

STORAGE

Avoid repeated freeze/thaw cycles. Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.

STABILITY

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
Int J Immunopathol Pharmacol Altered activities of kininase II, an angiotensin converting enzyme, prekallikrein, and nitric oxide in Kuwaiti patients with type 2 diabetes PubMed: 25964383
Thromb Res Factor XII–mediated contact activation related to poor prognosis in disseminated intravascular coagulation PubMed: 26706311
Thrombosis Research Factor XII-mediated contact activation related to poor prognosis in disseminated intravascular coaCavia (Guinea pig )lation Pubmed:26706311
Annals of Laboratory Medicine The First Case of Congenital Prekallikrein Deficiency in Korea With a Novel Pathogenic Variant (c. 1198G> T) Pubmed: 30430790
J Cell Mol Med Huaier shows anti©\cancer activities by inhibition of cell growth, migration and energy metabolism in lung cancer through PI3K/AKT/HIF©\1¦Á pathway 33377619
J Thromb Thrombolysis Contact system activation in disseminated intravascular coagulation: activities of prekallikrein and high-molecular-weight kininogen are significant risk factors Pubmed:34993714
Catalog No. Related products for research use of Homo sapiens (Human) Organism species Applications (RESEARCH USE ONLY!)
EPB801Hu62 Eukaryotic Prekallikrein (PK) Positive Control; Immunogen; SDS-PAGE; WB.
RPB801Hu01 Recombinant Prekallikrein (PK) Positive Control; Immunogen; SDS-PAGE; WB.
PAB801Hu01 Polyclonal Antibody to Prekallikrein (PK) WB; IHC
MAB801Hu22 Monoclonal Antibody to Prekallikrein (PK) WB; IHC; ICC; IP.
SEB801Hu ELISA Kit for Prekallikrein (PK) Enzyme-linked immunosorbent assay for Antigen Detection.
LMB801Hu Multiplex Assay Kit for Prekallikrein (PK) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.
CMB801Hu Multiplex Assay Kit for Prekallikrein (PK) ,etc. by CBA (Cytometric Bead Array) FLIA Kit for Antigen Detection.